SEC Filing Summary: Big Rock Partners Acquisition Corp. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on December 18, 2020, by Big Rock Partners Acquisition Corp. (BRPA), a Special Purpose Acquisition Company (SPAC) incorporated in Delaware. The filing reports on a special meeting of stockholders held on the same date to vote on proposals regarding the extension of the company's deadline to consummate an initial business combination.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. As a SPAC in the pre-business combination phase, the document focuses on corporate governance actions rather than operational financial performance.
Material Changes and Voting Results
Stockholders approved two key proposals at the special meeting:
- Extension of Business Combination Deadline: The company's charter was amended to extend the deadline to consummate an initial business combination to April 23, 2021.
- Early Winding Up Provision: Stockholders approved a proposal allowing for the early winding up of the company and redemption of 100% of outstanding public shares if the board determines the company cannot complete a business combination by the extended date.
Voting Tabulation for Extension Proposal:
| Vote Type | Count |
|---|---|
| For | 2,326,288 |
| Against | 116,901 |
| Abstain | 0 |
| Broker Non-Votes | 0 |
Voting Tabulation for Early Winding Up Proposal:
| Vote Type | Count |
|---|---|
| For | 2,323,788 |
| Against | 119,201 |
| Abstain | 200 |
| Broker Non-Votes | 0 |
Notably, no stockholders exercised their right to convert their shares into cash in connection with the extension.
Outlook, Risks, and Management Commentary
Following the meeting, the company filed the amendment to its Charter with the Delaware Secretary of State. The primary risk highlighted is the potential inability to consummate a business combination by the new deadline of April 23, 2021, which would trigger the early winding up and redemption process approved by shareholders. The filing does not contain specific management commentary on target acquisition prospects or market risks beyond the structural timeline changes.
Key Facts for Investor Verification
- Verify the new deadline for a business combination is April 23, 2021.
- Confirm that no shares were redeemed for cash during the extension vote.
- Review the amended Certificate of Incorporation (Exhibit 3.1) for specific terms regarding the early winding up provision.
- Note that the filing relates to Big Rock Partners Acquisition Corp., not NRX Pharmaceuticals, Inc., despite the metadata discrepancy.